BioSpyder Marks Presence in Japan Through Distribution Agreement with AS-ONE

BioSpyder Technologies, Inc. is pleased to announce its continued expansion into the Japanese market through a distribution agreement with AS-ONE, a leading supplier serving Japan’s scientific, laboratory, and research communities. 

This milestone follows BioSpyder’s repeated participation in the Japanese Society of Toxicology (JSOT) Annual Meeting, where the company has continued to engage with toxicology researchers, pharmaceutical scientists, and members of Japan’s broader life science community. After several visits to JSOT and growing interest in BioSpyder’s TempO-Seq™ platform, the agreement with AS-ONE represents an important step in making BioSpyder’s technologies more accessible to researchers throughout Japan. 

TempO-Seq enables high-throughput gene expression profiling with simplified workflows, scalable sample processing, and broad applicability across toxicology, drug discovery, environmental health, oncology, and translational research. By partnering with AS-ONE, BioSpyder aims to provide Japanese researchers with improved local access to its products, services, and technical support. 

The agreement with AS-ONE is part of BioSpyder’s broader commercial strategy to expand its global distribution network. In addition to Japan, BioSpyder has been actively onboarding distributors across multiple international markets to support growing demand for accessible, scalable, and cost-effective molecular profiling technologies. 

“This is an important step in BioSpyder’s global growth strategy,” said Garrett McComb, Director of BioSpyder Technologies. “As more researchers and organizations look for practical alternatives to traditional RNA sequencing, we want to make sure TempO-Seq is available through trusted regional partners who understand their local markets and customers.” 

BioSpyder’s expansion into Japan reflects the company’s continued commitment to supporting scientists worldwide with innovative tools that enable faster, more efficient, and more scalable gene expression analysis. 

For more information about TempO-Seq and BioSpyder’s innovative technologies, please visit BioSpyder’s at www.biospyder.com.